59 related articles for article (PubMed ID: 19155124)
1. Tetra-arsenic oxide (Tetras) enhances radiation sensitivity of solid tumors by anti-vascular effect.
Park SG; Jung JJ; Won HJ; Kang MS; Seo SK; Choi IW; Eun CK; Ahn KJ; Park CW; Lee SW; Lew YS; Bae IJ; Choi IH
Cancer Lett; 2009 May; 277(2):212-7. PubMed ID: 19155124
[TBL] [Abstract][Full Text] [Related]
2. Synergistic therapeutic effect of arsenic trioxide and radiotherapy in BALB/C nude mice bearing nasopharyngeal carcinoma xenografts.
Xie LX; Lin XH; Li DR; Chen JY; Hong CQ; Du CW
Exp Oncol; 2007 Mar; 29(1):45-8. PubMed ID: 17431388
[TBL] [Abstract][Full Text] [Related]
3. Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):197-203. PubMed ID: 15337556
[TBL] [Abstract][Full Text] [Related]
4. Study of arsenic trioxide-induced vascular shutdown and enhancement with radiation in solid tumor.
Monzen H; Griffin RJ; Williams BW; Amano M; Ando S; Hasegawa T
Radiat Med; 2004; 22(4):205-11. PubMed ID: 15468939
[TBL] [Abstract][Full Text] [Related]
5. Optimization of combination therapy of arsenic trioxide and fractionated radiotherapy for malignant glioma.
Ning S; Knox SJ
Int J Radiat Oncol Biol Phys; 2006 Jun; 65(2):493-8. PubMed ID: 16563655
[TBL] [Abstract][Full Text] [Related]
6. Use of arsenic trioxide as an antivascular and thermosensitizing agent in solid tumors.
Griffin RJ; Lee SH; Rood KL; Stewart MJ; Lyons JC; Lew YS; Park H; Song CW
Neoplasia; 2000; 2(6):555-60. PubMed ID: 11228548
[TBL] [Abstract][Full Text] [Related]
7. Arsenic trioxide enhances the therapeutic efficacy of radiation treatment of oral squamous carcinoma while protecting bone.
Kumar P; Gao Q; Ning Y; Wang Z; Krebsbach PH; Polverini PJ
Mol Cancer Ther; 2008 Jul; 7(7):2060-9. PubMed ID: 18645016
[TBL] [Abstract][Full Text] [Related]
8. [Relationship between radiotherapy enhancing effect of arsenic trioxide and the proliferation and apoptosis of related protein in nasopharyngeal carcinoma patients].
Lin YC; Li DR; Lin W
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):704-7. PubMed ID: 17879533
[TBL] [Abstract][Full Text] [Related]
9. Antitumor effect and mechanisms of arsenic trioxide on subcutaneously implanted human gastric cancer in nude mice.
Wu DD; Xiao YF; Geng Y; Hou J
Cancer Genet Cytogenet; 2010 Apr; 198(2):90-6. PubMed ID: 20362223
[TBL] [Abstract][Full Text] [Related]
10. Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
Chien CW; Yao JH; Chang SY; Lee PC; Lee TC
Toxicol Appl Pharmacol; 2011 Nov; 257(1):59-66. PubMed ID: 21889949
[TBL] [Abstract][Full Text] [Related]
11. Synergistic interaction with arsenic trioxide and fractionated radiation in locally advanced murine tumor.
Lew YS; Kolozsvary A; Brown SL; Kim JH
Cancer Res; 2002 Aug; 62(15):4202-5. PubMed ID: 12154019
[TBL] [Abstract][Full Text] [Related]
12. Comparison of optical and power Doppler ultrasound imaging for non-invasive evaluation of arsenic trioxide as a vascular disrupting agent in tumors.
Alhasan MK; Liu L; Lewis MA; Magnusson J; Mason RP
PLoS One; 2012; 7(9):e46106. PubMed ID: 23029403
[TBL] [Abstract][Full Text] [Related]
13. Solid tumors subsequent to arsenic trioxide treatment for acute promyelocytic leukemia.
Au WY; Kumana CR; Lam CW; Cheng VC; Shek TW; Chan EY; Liu R; Kwong YL
Leuk Res; 2007 Jan; 31(1):105-8. PubMed ID: 16725199
[TBL] [Abstract][Full Text] [Related]
14. Arsenic trioxide causes selective necrosis in solid murine tumors by vascular shutdown.
Lew YS; Brown SL; Griffin RJ; Song CW; Kim JH
Cancer Res; 1999 Dec; 59(24):6033-7. PubMed ID: 10626785
[TBL] [Abstract][Full Text] [Related]
15. Differentiation of human nasopharyngeal carcinoma xenografts and repression of telomerase activity induced by arsenic trioxide.
Du C; Li D; Lin Y; Wu M
Natl Med J India; 2004; 17(2):67-70. PubMed ID: 15141597
[TBL] [Abstract][Full Text] [Related]
16. The growth-inhibitory and apoptosis-inducing effect of deferoxamine combined with arsenic trioxide on HL-60 xenografts in nude mice.
Yu R; Wang D; Ren X; Zeng L; Liu Y
Leuk Res; 2014 Sep; 38(9):1085-90. PubMed ID: 24908354
[TBL] [Abstract][Full Text] [Related]
17. Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor kappaB.
Wei LH; Lai KP; Chen CA; Cheng CH; Huang YJ; Chou CH; Kuo ML; Hsieh CY
Oncogene; 2005 Jan; 24(3):390-8. PubMed ID: 15531921
[TBL] [Abstract][Full Text] [Related]
18. Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.
Zhu HH; Wu DP; Jin J; Li JY; Ma J; Wang JX; Jiang H; Chen SJ; Huang XJ
J Clin Oncol; 2013 Nov; 31(33):4215-21. PubMed ID: 24127444
[TBL] [Abstract][Full Text] [Related]
19. Using targeted magnetic arsenic trioxide nanoparticles for osteosarcoma treatment.
Li XS; Li WQ; Wang WB
Cancer Biother Radiopharm; 2007 Dec; 22(6):772-8. PubMed ID: 18158768
[TBL] [Abstract][Full Text] [Related]
20. Effect of the tumor vascular-damaging agent, ZD6126, on the radioresponse of U87 glioblastoma.
Wachsberger PR; Burd R; Marero N; Daskalakis C; Ryan A; McCue P; Dicker AP
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):835-42. PubMed ID: 15701874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
